Gabi 期刊-仿造药和生物仿造药建议期刊 SCIE

期刊简介估计审稿时候：

The GaBI Journal Generics and Biosimilars Initiative Journal (GABI J) is an academic journal dedicated to the field of generic drugs and biosimilars. This journal is committed to promoting the research, development, and application of generic drugs and biosimilars, providing an important communication platform for academia and industry.

GABI J is published or managed by Pro Pharma Communications International and is located in Belgium. This journal has been included in authoritative databases such as Emerging Sources Citation Index (ESCI), demonstrating its significant influence in the fields of generic drugs and biosimilars. At the same time, GABI J also provides paper editing, translation, typesetting and other services through platforms such as LetPub, helping global authors publish high-quality research papers smoothly.

《Gabi 期刊-仿造药和生物仿造药建议期刊》（简称GABI J）是一本专一于仿造药（Generics）和生物近似药（Biosimilars）范畴的学术期刊。该期刊努力于鞭策仿造药和生物近似药的研讨、开辟与利用，为学术界和财产界供给了一个主要的交换平台。

GABI J由Pro Pharma Communications International出书或办理，出书地位于比利时（Belgium）。该期刊被Emerging Sources Citation Index (ESCI)等权势巨子数据库收录，显现出其在仿造药和生物近似药范畴的必然影响力。同时，GABI J还经由过程LetPub等平台供给论文编辑、翻译、排版等办事，助力环球作者顺遂颁发高品质的研讨论文。

若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。